Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycystic Ovary Syndrome × Therapeutics × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 29 Fatigue 23 Depression 22 Prostatic Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 14 Multiple Myeloma 13 Colorectal Neoplasms 13 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Lung Neoplasms 11 Leukemia, Myeloid, Acute 11 Hodgkin Disease 11 Leukemia, Myeloid, Chronic-Phase 10 Blast Crisis 10 Pain 9 Lymphoma, T-Cell, Cutaneous 9 Leukemia, Myeloid, Accelerated Phase 9 Leukemia, Hairy Cell 9 Anxiety Disorders 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8 Carcinoma, Ovarian Epithelial 8 Vomiting 7 Sezary Syndrome 7

Interventions

Metformin 122 Clomiphene 39 Letrozole 32 Inositol 24 Progesterone 15 Folic Acid 15 Exercise 14 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Caloric Restriction 12 Estradiol 11 Contraceptives, Oral 11 cetrorelix 10 Chorionic Gonadotropin 10 Triptorelin Pamoate 9 Pioglitazone 9 Tablets 8 Spironolactone 8 High-Intensity Interval Training 8 Diet 8 Cholecalciferol 8 Menotropins 7 Gonadotropins 7 Acupuncture Therapy 7 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Flutamide 6 Exenatide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00378729 2011-10-04

PERCING

Assistance Publique - Hôpitaux de Paris

Phase 4 Unknown

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡